| dc.creator |
YÜCEL, Hakan; GAZİANTEP ŞEHİTKAMİL DEVLET HASTANESİ |
|
| dc.creator |
TABUR, Suzan; GAZİANTEP ÜNİVERSİTESİ, TIP FAKÜLTESİ |
|
| dc.creator |
ÖZTÜRK, Sadettin; GAZİANTEP ÜNİVERSİTESİ, TIP FAKÜLTESİ |
|
| dc.creator |
ARAZ, Mustafa; GAZİANTEP ÜNİVERSİTESİ, TIP FAKÜLTESİ |
|
| dc.creator |
ÇOLAKOĞLU ER, Hale; GAZİANTEP ÜNİVERSİTESİ, TIP FAKÜLTESİ |
|
| dc.creator |
VURUSKAN, Ertan; GAZİANTEP ÜNİVERSİTESİ, TIP FAKÜLTESİ |
|
| dc.date |
2021-09-13T00:00:00Z |
|
| dc.date.accessioned |
2021-12-03T11:46:53Z |
|
| dc.date.available |
2021-12-03T11:46:53Z |
|
| dc.identifier |
https://dergipark.org.tr/tr/pub/sdutfd/issue/64881/866770 |
|
| dc.identifier |
10.17343/sdutfd.866770 |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/94103 |
|
| dc.description |
AmaçHashimoto tiroiditi otoimmün tiroid hastalığıdır. Aterosklerozdaarterlerin subintima tabakasında lipidler,karbonhidratlar, fibröz doku, kalsiyum gibi maddelerinlokal birikimlerinin oluşturduğu patolojik bir durumsöz konusudur. Vasküler endotelyal büyüme faktör(VEGF) özellikle hipoksi varlığında seçici olarak endotelhücrelerinde mitojenik etki ile damar gelişiminiuyararak yeni damar oluşumunda yaşamsal rol oynar.Biz bu çalışmamızda ötiroid hashimoto hastalarındaserum VEGF düzeyi ile akım aracılı dilatasyon(flow-mediated dilation, FMD) ve karotis intima mediakalınlığı (KİMK) ölçümü yaparak, otoimmünitenin tiroidhastalarında ateroskleroz ile ilişkisini ortaya koymayıamaçladık.Gereç ve YöntemGaziantep Üniversitesi Tıp Fakültesi Dahiliye Kliniği’ndeHashimoto tiroiditi tanısı almış 40 hasta ile yaşve cinsiyet uyumlu 40 sağlıklı gönüllü çalışmaya dahiledildi. Serum örneklerinde VEGF düzeyleri ELISAyöntemiyle ölçüldü. Hasta ve kontrol grubunda ultrasoneşliğinde KİMK ve FMD değerlendirilerek mevcutsonuçlarla ilişkili olup olmadığı tespit edildi.BulgularHasta ve kontrol grubunun demografik özellikleri benzerdi.Hasta ve kontrol grupları arasında FMD veKIMK ölçümleri karşılaştırıldığında istatiksel olarakanlamlı fark saptandı (p=0,001; p=0,033). VEGF düzeyininde hasta grubunda kontrol grubuna göre anlamlıolarak yüksek olduğu tespit edildi (p=0,024).SonuçTüm bu sonuçlar tiroid hormon eksikliği olmadan daotoimmüniteye sekonder ateroskleroz gelişebileceğinive hashimoto hastalarının erken dönem takiplerindenoninvaziv uygulanabilen FMD, KİMK ölçümlerinin veVEGF düzeylerinin prediktif değerinin olabileceğinigöstermektedir. |
|
| dc.description |
ObjectiveHashimoto thyroiditis is an autoimmune thyroiddisease. Atherosclerosis is a pathological conditioncharacterized by local accumulation of substancessuch as lipids, carbohydrates, fibrous tissue andcalcium in the subintima layer of arteries. In thisstudy, we aimed to reveal the relationship betweenautoimmunity and atherosclerosis by measuringserum VEGF levels, flow-mediated dilation (FMD)and carotid intima-media thicknes (CIMT) in euthyroidpatients with Hashimoto thyroiditis.Materials and MethodsForty patients diagnosed with Hashimoto thyroiditis inthe Internal Medicine Clinic of Gaziantep UniversityMedical Faculty and 40 healthy volunteers matchedfor age and gender were included in the study.VEGF levels were measured by ELISA method inserum samples. CIMT and FMD were evaluatedwith ultrasound guidance in the patient and controlgroups and it was determined whether there was aassociation with the present results.ResultsThe demographic characteristics of the patient andcontrol groups were similar. There was a significantdifference between the patients and healthy controlgroup in terms of FMD and CIMC measurements (p =0.001; p = 0.033). It was also found that VEGF levelsof patients were higher than those in the control group(p = 0.024).ConclusionAll these results show autoimmunity may leadatherosclerosis even without thyroid hormonedeficiency and also noninvasive FMD, CIMTmeasurements and VEGF levels may have predictivevalue in the early follow-up of Hashimoto patients. |
|
| dc.format |
application/pdf |
|
| dc.language |
tr |
|
| dc.publisher |
Süleyman Demirel Üniversitesi |
|
| dc.publisher |
Süleyman Demirel University |
|
| dc.relation |
https://dergipark.org.tr/tr/download/article-file/1527983 |
|
| dc.source |
Volume: 28, Issue: 3
449-454 |
en-US |
| dc.source |
1300-7416 |
|
| dc.source |
2602-2109 |
|
| dc.source |
SDÜ Tıp Fakültesi Dergisi |
|
| dc.subject |
Hashimoto tiroiditi,Ateroskleroz,VEGF,KİMT,FMD |
|
| dc.subject |
Atherosclerosis,VEGF,CIMT,FMD,Hashimoto |
|
| dc.title |
HASHİMOTO TİROİDİTLİ HASTALARDA ATEROSKLEROZ İLE İLİŞKİLİ PARAMETRELERİN DEĞERLENDİRİLMESİ |
tr-TR |
| dc.title |
THE EVALUATION OF ATHEROSCLEROSIS RELATED PARAMETERS IN PATIENTS WITH HASHIMOTO’S THYROIDITIS |
en-US |
| dc.type |
info:eu-repo/semantics/article |
|
| dc.citation |
1. Ahmed R, Al-Shaikh S, Akhtar M. Hashimoto thyroiditis: a century
later. Adv Anat Pathol 2012;19(3);181-186. |
|
| dc.citation |
2. Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J
Med 2003;348:2455-2646. |
|
| dc.citation |
3. Murray CJ, Lopez AD. Global mortality, disability, and the contribution
of risk factors: Global Burden of Disease Study. Lancet
1997;349(9063):1436-42. |
|
| dc.citation |
4. Kumral E. Aterosklerozun Epidemiyolojisi ve Genel Özellikleri:
Kumral E. Ateroskleroz ve Serebrovasküler Hastalıklar (1. Baskı)
İstanbul, Tayf Matbacılık, 2003; 3-9. |
|
| dc.citation |
5. Erişim: www.tmc.edu/thi/cad.html Erişim Tarihi: 1/09/2005. |
|
| dc.citation |
6. Kasper DL, Hauser SL, LongoDL, Jameson JL. Çeviri editoru:
Sağlıker Y. Harrison İç Hastalıkları Prensipleri (15. Baskı) İstanbul,
Nobel Matbaacılık, 2004; 2060-75. |
|
| dc.citation |
7. Wang Y, Nakayama M, Pitulescu ME, Schmidt TS. Ephrin-B2
Controls VEG İinduced Angiogenesis and Lymphangiogenesis.
Nature 2010; 465: 483-486. |
|
| dc.citation |
8. O'Leary DH, Polak JF. Intima-Media Thickness: a tool for atherosclerosis
imaging and event prediction. Am J Cardiol 2002;
90: 18L-21L |
|
| dc.citation |
9. Kingwell BA. Wall changes induced by blood pressure and antihypertensive
drugs in large arteries: Touboul PJ, Hennerici M. Intima-
Media Thickness, Drugs and Stroke .(1. Baskı) 2002; 19-24. |
|
| dc.citation |
10. Weissberg P. Mechanisms modifying atherosclerotic disease
from lipids to vascular biology. Atherosclerosis 1999;147(1): 3-10. |
|
| dc.citation |
11. Yoshida T, Kawano H, Miyamoto S, Motoyama T, Fukushima H,
Hirai N, Ogawa H. Prognostic value of flow-mediated dilation
of the brachial artery in patients with cardiovascular disease.
Internal medicine 2006; 45: 575-9. |
|
| dc.citation |
12. Neunteufl T, Heher S, Katzenschlager R. Late prognosticvalue
of FMD in the brachial artery of patients with chest pain. Am J
Cardiol 2000; 86: 207-210. |
|
| dc.citation |
13. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis
GJ. Compensatory enlargement of human atherosclerotic
coronary arteries. New England Journal of Medicine 1987, 316
(22): 1371-1375. |
|
| dc.citation |
14. Reinehr T, Kiess W, Sousa G, Stoffel-Wagner B, Wunsch R.
Intima media thickness in childhood obesity: Relations to inflammatory
marker, glucose metabolism, and blood pressure.
Metabolism. Clinical and Experimental 2006;55:113- 118. |
|
| dc.citation |
15. Frostegård J. Atherosclerosis in patients with autoimmune disorders.
Arterioscler Thromb Vasc Biol 2005; 25(9):1776-85. |
|
| dc.citation |
16. Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni L
ve ark. Low-grade systemic inflammation causes endothelial dysfunction
in patients with Hashimoto’s thyroiditis. The Journal of
Clinical Endocrinology & Metabolism 2006; 91(12):5076-5082. |
|
| dc.citation |
17. Allan PL, Mowbray PI, Lee AJ. Relationship between carotid intima-
media thickness and symptomatic and asymptomatic peripheral
arterial disease. Edinburgh Artery Study. Stroke 1997;
28:348- 353 |
|
| dc.citation |
18. Nagasaki T, Inaba M, Henmi Y, Kumeda Y, Ueda M, Tahara H
ve ark. Decrease in carotid intima-media thickness in hypothyroid
patients after normalization of thyroid function. Clin Endocrinol
(Oxf). 2003; 59:607-12. |
|
| dc.citation |
19. Monzani F, Caraccio N, Kozàkowà M, Dardano A, Vittone F,
Virdis A ve ark. Effect of levothyroxine replacement on lipid profile
and intima-media thickness in subclinical hypothyroidism: a
double-blind, placebo-controlled study. The Journal of Clinical
Endocrinology & Metabolism 2004; 89(5 ): 2099-2106. |
|
| dc.citation |
20. Topaloglu, Oya, et al. Is autoimmune thyroiditis a risk factor for
early atherosclerosis in premenopausal women even if in euthyroid
status?. Endocrine 2013; 44(1): 145-151. |
|
| dc.citation |
21. Hofbauer LC, Kluger S, Kuhne CA, Dunstan CR, Burchert A,
Schoppet M ve ark. Detection and characterization of RANK
ligand and osteoprotegerin in the thyroid gland. J Cell Biochem
2002; 86: 642-50. |
|
| dc.citation |
22. Armstrong AW, Voyles SV, Armstrong EJ, Fuller EN, Rutledge
JC. Angiogenesis and oxidative stress: common mechanisms
linking psoriasis with atherosclerosis. J Dermatol Sci 2011; 63:
1–9 |
|
| dc.citation |
23. Bhushan M, McLaughlin B, Weiss JB, Griffiths CE. Levels of
endothelial cell stimulating angiogenesis factor and vascular
endothelial growth factor are elevated in psoriasis. Br J Dermatol
1999; 141: 1054–1060. |
|
| dc.citation |
24. Mohammad NS, Elsayed N, Bassiouny R. Increased production
of vascular endothelial growth factor in the lesions of psoriasis–
a new target for future therapy. J Med Res Inst 2008; 29:
81–86 |
|
| dc.citation |
25. Inoue M, Itoh H, Ueda M, Naruko T, Kojima A, Komatsu R ve
ark. Vascular endothelial growth factor (VEGF) expression in
human coronary atherosclerotic lesions: possible pathophysiological
significance of VEGF in progression of atherosclerosis.
Circulation 1998; 98(20):2108-16. |
|
| dc.citation |
26. Mohammad NS, Elsayed N, Bassıouny R. Increased production
of vascular endothelial growth factor in the lesions of psoriasis–
a new target for future therapy. Journal Of Medıcal Research
Instıtute 2008; 29.1: 81-86. |
|
| dc.citation |
27. Neunteufl T, Heher S, Katzenschlager R, Kostner K, Maurer G,
Weidinger F. Late prognostic value of FMD in the brachial artery
of patients with chest pain Am J Cardiol 2000;86:207-210 |
|
| dc.citation |
28. Xiang GD, He YS, Zhao LS, Hou J, Yue L, Xiang HJ. Impairment
of endothelium-dependent arterial dilation in Hashimoto's
thyroiditis patients with euthyroidism. Clin Endocrinol (Oxf)
2006;64(6):698-702. |
|